Abstract:We have read with interest the recent study by Le Nevé et al1Le Neve B. et al.Clin Gastroenterol Hepatol. 2016; 14: 226-233 e3Abstract Full Text Full Text PDF Scopus (34) Google Scholar that assessed visceral sensitivity and symptom severity in patients with irritable bowel syndrome (IBS) following a combined nutrient and lactulose challenge. The authors report that symptom severity assessed by validated questionnaires was significantly higher in patients with “high-intensity gastrointestinal (GI) symptoms” compared with those with “low-intensity GI symptoms” after the test meal. The high-intensity GI symptoms group also had high levels of anxiety and elevated Visceral Sensitivity Index scores (both P < .05). Furthermore, compared with the low-intensity GI symptoms group, patients in the high-intensity GI symptoms group had higher rectal sensitivity to phasic distentions administered by an electronic barostat (P < .05–.001). It is well known that patients with functional GI disorders are more likely to report food intolerance than healthy individuals.2Bohn L. et al.Am J Gastroenterol. 2013; 108: 634-641Google Scholar, 3Zheng X. et al.Neurogastroenterol Motil. 2015; 27: 1138-1146Google Scholar Indeed, the striking similarity between IBS and food intolerance symptoms suggests that malabsorption of certain foods (eg, fermentable oligosaccharides, disaccharides, monosaccharides, and polyols [FODMAP]) is an important cause of abdominal symptoms in many patients with IBS.4Shepherd S.J. et al.Clin Gastroenterol Hepatol. 2008; 6: 765-771Google Scholar, 5Halmos E.P. et al.Gastroenterology. 2014; 146: 67-75 e5Google Scholar Chemically similar to lactulose, lactose is a disaccharide FODMAP in patients with lactase deficiency. China is a country with a >95% prevalence of primary, genetic lactase deficiency6Yang J. et al.Clin Gastroenterol Hepatol. 2013; 11: 262-268 e1Google Scholar that has seen a large increase in milk consumption in recent years. This combination of genetic susceptibility and environmental challenge may have contributed to the increasing incidence of IBS documented in this population. The lactose hydrogen breath test is a simple, noninvasive investigation for the assessment of lactose absorption and tolerance. Our work in the Chinese population has shown that ingestion of 40-g lactose leads to lactose intolerance in health and disease; however, at the relatively low 20-g lactose dose, symptoms were more than 3 times more common in patients with IBS than in healthy control subjects.6Yang J. et al.Clin Gastroenterol Hepatol. 2013; 11: 262-268 e1Google Scholar In subsequent studies we applied the 20-g lactose hydrogen breath test as a clinical experimental model to identify the factors that determine the increased risk of bloating and functional GI symptoms after lactose ingestion in patients with IBS.6Yang J. et al.Clin Gastroenterol Hepatol. 2013; 11: 262-268 e1Google Scholar, 7Yang J. et al.Aliment Pharmacol Ther. 2014; 39: 302-311Google Scholar, 8Zhu Y. et al.Am J Gastroenterol. 2013; 108: 1516-1525Google Scholar Consistent with findings for the combined nutrient and lactulose challenge,1Le Neve B. et al.Clin Gastroenterol Hepatol. 2016; 14: 226-233 e3Abstract Full Text Full Text PDF Scopus (34) Google Scholar a large case-control study by Zhu et al8Zhu Y. et al.Am J Gastroenterol. 2013; 108: 1516-1525Google Scholar found that the presence of visceral hypersensitivity on rectal barostat studies increased the risk of bloating (odds ratio, 6.61; P = .005) and overall abdominal symptoms (odds ratio, 3.78; P = .014) after ingestion of 20-g lactose. Additionally, the onset of symptoms was closely related to the timing of gas production and high levels of gas production increased the risk of abdominal symptoms (odds ratio, 2.19; P = .028). The fact that Le Nevé et al1Le Neve B. et al.Clin Gastroenterol Hepatol. 2016; 14: 226-233 e3Abstract Full Text Full Text PDF Scopus (34) Google Scholar did not detect the latter effect may be caused by the larger number of subjects in the Chinese study (277 vs 100 patients with IBS). Also previous exposure to dairy products in the Chinese population may have promoted bacteria that metabolize lactose, whereas lactulose is not part of a normal diet (ie, increased sensitivity of H2 breath testing). Together these findings are consistent with the principle that both the size of the stimulus (eg, gas distention) and sensitivity to the stimulus contribute to symptom generation after FODMAP intake. The consistent finding of visceral hypersensitivity in patients with IBS with food intolerance emphasizes the importance of this pathology in functional GI disease.1Le Neve B. et al.Clin Gastroenterol Hepatol. 2016; 14: 226-233 e3Abstract Full Text Full Text PDF Scopus (34) Google Scholar, 7Yang J. et al.Aliment Pharmacol Ther. 2014; 39: 302-311Google Scholar, 8Zhu Y. et al.Am J Gastroenterol. 2013; 108: 1516-1525Google Scholar Looking ahead, FODMAP challenge tests may help to identify the causes of IBS symptoms and to direct more specific and effective therapy. Lactulose Challenge Determines Visceral Sensitivity and Severity of Symptoms in Patients With Irritable Bowel SyndromeClinical Gastroenterology and HepatologyVol. 14Issue 2PreviewPatients with irritable bowel syndrome (IBS) can be assigned to groups with different gastrointestinal (GI) symptoms based on results from a combined nutrient and lactulose challenge. We aimed to identify factors that predict outcomes to this challenge and to determine whether this can be used in noninvasive assessment of visceral sensitivity in patients with IBS. Full-Text PDF

Fecal lactoferrin in discriminating inflammatory bowel disease from Irritable bowel syndrome: a diagnostic meta-analysis

Relationship Between Fecal Lactoferrin and Inflammatory Bowel Disease

A study of the methodological and clinical validity of the combined lactulose hydrogen breath test with scintigraphic oro-cecal transit test for diagnosing small intestinal bacterial overgrowth in IBS patients.

Prevalence and presentation of lactose intolerance and effects on dairy product intake in healthy subjects and patients with irritable bowel syndrome.

Dietary Challenge Tests: Identifying Food Intolerance As a Cause of Symptoms in Irritable Bowel Syndrome Patients.

Sa1397 the Prevalence, Clinical Relevance and Impact on Diet of Lactose Intolerance in a Population with Lactase Deficiency: A Randomized, Double-Blind, Dose Response Study in Healthy Subjects and Patients with Diarrhea Predominant Irritable Bowel Syndrome

Clinical significance of serum anti-microbial antibodies test in inflammatory bowel disease

Diagnostic value of serum proteome characters analyzed by proteomic fingerprint technology in patients with inflammatory bowel disease

Confluent granulomas and ulcers lined by epithelioid histiocytes: new ideal method for differentiation of ITB and CD? A meta analysis.

IDDF2019-ABS-0186 Correlation Between Serological Biomarkers and Disease Activity in Patients with Inflammatory Bowel Disease

Diagnostic performance of 18F-FDG-PET versus scintigraphy in patients with inflammatory bowel disease: a meta-analysis of prospective literature.

Fecal calprotectin in differential diagnosis of irritable bowel syndrome]

Clinical Significance of Faecal Calprotectin in Differentiating Inflammatory Bowel Disease from Irritable Bowel Syndrome

Alterations in Fecal Short-Chain Fatty Acids in Patients with Irritable Bowel Syndrome

P288 Fecal leukocyte esterase level can predict endoscopic activity for Inflammatory Bowel Disease patients

Changes in Fecal Short-Chain Fatty Acids in IBS Patients and Effects of Different Interventions: A Systematic Review and Meta-Analysis

Detection of biomarkers and its clinical signiifcance in the inlfammatory bowel disease in Children

Alterations of fecal short-chain fatty acids in patients with irritable bowel syndrome: A systematic review and meta-analysis

Evaluation of a Fluorescent Immunochromatography Test for Fecal Calprotectin

P380 Integrated fecal metagenome and serum metabolome analysis revealed gut microbiome associated serum metabolites as diagnostic biomarkers for inflammatory bowel disease